LEADER 07401nam a2200757 4500
001 ocn794228037
003 OCoLC
005 20170124071819.8
006 m o d
007 cr cn|||||||||
008 120522s2013 enk ob 001 0 eng
010 |a  2012021077 
040 |a DLC  |b eng  |e pn  |c DLC  |d YDX  |d N$T  |d DG1  |d YDXCP  |d STF  |d E7B  |d DOS  |d UBY  |d EMU  |d NLGGC  |d OCLCF  |d OCLCQ  |d OCLCO  |d OCLCQ  |d DG1  |d GrThAP 
020 |a 9781118454473  |q (Adobe PDF) 
020 |a 1118454472  |q (Adobe PDF) 
020 |a 9781118454480  |q (ePub) 
020 |a 1118454480  |q (ePub) 
020 |a 9781118454497  |q (MobiPocket) 
020 |a 1118454499  |q (MobiPocket) 
020 |a 9781118454503 
020 |a 1118454502 
020 |z 9781118134153  |q (pbk.) 
029 1 |a AU@  |b 000049174745 
029 1 |a DKDLA  |b 820120-katalog:000600120 
029 1 |a NZ1  |b 14976608 
029 1 |a GBVCP  |b 863146015 
035 |a (OCoLC)794228037 
042 |a pcc 
050 0 0 |a RC564.15 
060 1 0 |a WM 270 
072 7 |a SEL  |x 013000  |2 bisacsh 
072 7 |a SEL  |x 026000  |2 bisacsh 
072 7 |a SEL  |x 029000  |2 bisacsh 
082 0 0 |a 616.86/06  |2 23 
049 |a MAIN 
100 1 |a Abraha, Iosief. 
245 1 0 |a Alcohol and drug misuse /  |c Iosief Abraha, Cristina Cusi. 
264 1 |a Chichester, West Sussex :  |b John Wiley & Sons,  |c 2013. 
300 |a 1 online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Cochrane handbook 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record and CIP data provided by publisher. 
505 0 |a Part 1. Alcohol. Psychosocial interventions -- Effectiveness of brief alcohol interventions in primary care populations -- Brief interventions for heavy alcohol users admitted to general hospital wards -- Alcoholics Anonymous and other 12-step programmes for alcohol dependence -- Mentoring adolescents to prevent substance use disorders -- Universal school-based prevention programmes for alcohol misuse in young people -- Universal multicomponent prevention programmes for alcohol misuse in young people -- Universal family-based prevention programmes for alcohol misuse in young people -- Social norms interventions to reduce alcohol misuse in university or college students -- Psychosocial interventions for women enrolled in alcohol treatment during pregnancy -- Pharmacological interventions -- Benzodiazepines for alcohol withdrawal -- Anticonvulsants for alcohol withdrawal -- Acamprosate for alcohol dependence -- Baclofen for alcohol withdrawal -- Gamma-hydroxybutyrate for treatment of alcohol withdrawal and prevention of relapse -- Psychotropic analgesic nitrous oxide for alcohol withdrawal -- Efficacy and safety of pharmacological interventions for the treatment of alcohol withdrawal -- Opioid antagonists for alcohol dependence -- Pharmacologic interventions for pregnant women enrolled in alcohol treatment. 
505 0 |a Part 2. Drugs. Psychosocial interventions -- School-based prevention for illicit substance use disorders -- Interventions for prevention of substance use disorders by young people delivered in non-school settings -- Case management for persons with substance use disorders -- Motivational interviewing for substance use disorders -- Therapeutic communities for substance use disorders -- Interventions for drug-using offenders in the courts, secure estabishments and the community -- Psychosocial interventions for pregnant women in outpatient illicit drug treatment programmes compared to other interventions -- Cocaine dependence -- Psychosocial interventions for cocaine and psychostimulant amphetamine related disorders -- Antidepressants for cocaine dependence -- Antipsychotic medications for cocaine dependence -- Anticonvulsants for cocaine dependence -- Dopamine agonists for cocaine dependence -- Disulfiram for the treatment of cocaine dependence -- Efficacy of psychostimulant drugs for cocaine dependence -- Auricular acupuncture for cocaine dependence -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Psychosocial treatment for opiate dependence -- Psychosocial and pharmacological treatments versus pharmacological treatments for opioid detoxification -- Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence -- Alpha2-adrenergic agonists for the management of opioid withdrawal -- Buprenorphine for the management of opioid withdrawal -- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence -- Methadone at tapered doses for the management of opioid withdrawal -- Methadone maintenance at different dosages for opioid dependence -- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence -- Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal -- Opioid antagonists with minimal sedation for opioid withdrawal -- Oral naltrexone maintenance treatment for opioid dependence -- Sustained-release naltrexone for opioid dependence -- Heroin maintenance for chronic heroin-dependent individuals -- LAAM maintainance verus methadone maintenance for heroin dependence -- Detoxification treatments for opiate-dependent adolescents -- Maintenance treatments for opiate-dependent adolescents -- Maintenance agonist treatment for opiate-dependent adolescents -- Maintenance agonist treatments for opiate-dependent pregnant women -- Pharmacological treatments for depression during opoid dependence -- Inpatient versus other setttings for detoxification for opiod dependence -- Psychotherapeutic interventions for cannabis use or dependence in outpatient settings -- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings -- Treatment for amphetamine dependence -- Treatment for amphetamine withdrawal -- Treatment for amphetamine psychosis -- Treatment for methaqualone dependence in adults. 
650 0 |a Drug abuse  |x Treatment. 
650 0 |a Alcoholism  |x Treatment. 
650 2 |a Substance-Related Disorders  |x therapy. 
650 2 |a Comparative Effectiveness Research. 
650 2 |a Early Medical Intervention. 
650 2 |a Social Support. 
650 7 |a SELF-HELP  |x Substance Abuse & Addictions  |x Drug Dependence.  |2 bisacsh 
650 7 |a SELF-HELP  |x Substance Abuse & Addictions  |x General.  |2 bisacsh 
650 7 |a SELF-HELP  |x Twelve-Step Programs.  |2 bisacsh 
650 7 |a Alcoholism  |x Treatment.  |2 fast  |0 (OCoLC)fst00804565 
650 7 |a Drug abuse  |x Treatment.  |2 fast  |0 (OCoLC)fst00898588 
655 2 |a Review. 
655 4 |a Electronic books. 
700 1 |a Cusi, Cristina. 
710 2 |a Cochrane Collaboration. 
776 0 8 |i Print version:  |a Abraha, Iosief.  |t Alcohol and drug misuse.  |d Chichester, West Sussex : John Wiley & Sons, 2013  |z 9781118134153  |w (DLC) 2012020172 
830 0 |a Cochrane book series. 
856 4 0 |u https://doi.org/10.1002/9781118454503  |z Full Text via HEAL-Link 
994 |a 92  |b DG1